Skip to content

Impact of Dissection Area on the Clinical Outcome of Endoscopic Thyroidectomy

Clinical Benefits of Reduced Subcutaneous Dissection in Endoscopic Thyroidectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01338597
Acronym
ET
Enrollment
40
Registered
2011-04-19
Start date
2011-04-30
Completion date
2012-06-30
Last updated
2011-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Tumor

Keywords

thyroidectomy, invasiveness

Brief summary

The purpose of this study is to investigate whether reduced subcutaneous dissection area could offer patients more clinical benefits.

Detailed description

To create a working place in the chest wall is an inevitable step of endoscopic thyroidectomy. Large subcutaneous area was considered a drawback of endoscopic thyroidectomy. The purpose of this study is to investigate whether subcutaneous dissection area has influence on clinical outcome of endoscopic thyroidectomy, such as post-operative pain, complication rate and post-operative discomfort.

Interventions

endoscopic thyroidectomy via the breast approach. the difference between two arms is in the subcutaneous dissection area.

Sponsors

Second Military Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* thyroid nodule diagnosed by ultrasound * willing to undergo endoscopic thyroidectomy

Exclusion criteria

* conversion to open surgery * unwilling to join the research

Design outcomes

Primary

MeasureTime frameDescription
post-operative pain24h post-operation24hs after operation, post-operative pain is evaluated by VAS(visual analoge scale)

Secondary

MeasureTime frameDescription
number of patients with adverse effectwithin 3 months after surgeryrecord how many patients had adverse effects(eg. bruise, seroma, hematoma, hoarseness,hypocalciemia)

Countries

China

Contacts

Primary Contactwei zhang, MD
zhangwei412@yahoo.com.cn-8621-81885802
Backup Contactming qiu, MD
qiuming2006@yahoo.cn8621-81885801

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026